Rufinamide demonstrated favorable efficacy and was generally well tolerated when used as adjunctive treatment for adults with LGS. < /p > < /span > < span class= " a-plus-plus abstract-section id-a-sec5 " > < h3 class= " a-plus-plus " > Funding < /h3 > < p class= " a-plus-plus " > Eisai. < /p > < /span >..."> Rufinamide demonstrated favorable efficacy and was generally well tolerated when used as adjunctive treatment for adults with LGS. < /p > < /span > < span class= " a-plus-plus abstract-section id-a-sec5 " > < h3 class= " a-plus-plus " > Funding < /h3 > < p class= " a-plus-plus " > Eisai. < /p > < /span >..." /> Rufinamide demonstrated favorable efficacy and was generally well tolerated when used as adjunctive treatment for adults with LGS. < /p > < /span > < span class= " a-plus-plus abstract-section id-a-sec5 " > < h3 class= " a-plus-plus " > Funding < /h3 > < p class= " a-plus-plus " > Eisai. < /p > < /span >..." />

Treatment of Adults with Lennox –Gastaut Syndrome: Further Analysis of Efficacy and Safety/Tolerability of Rufinamide

Conclusion < /h3 > < p class= " a-plus-plus " > Rufinamide demonstrated favorable efficacy and was generally well tolerated when used as adjunctive treatment for adults with LGS. < /p > < /span > < span class= " a-plus-plus abstract-section id-a-sec5 " > < h3 class= " a-plus-plus " > Funding < /h3 > < p class= " a-plus-plus " > Eisai. < /p > < /span >
Source: Neurology and Therapy - Category: Neurology Source Type: research